Clinical Perspectives on Long-Term Albumin Therapy in Decompensated Cirrhosis: A Nationwide Delphi Survey in Spain-The ALBA Study.

ABSTRACT:

Background and aims

Albumin is well established for some acute indications in decompensated cirrhosis, but its long-term use remains controversial. The ALBA study explored expert clinical perspectives, barriers, and current practices regarding long-term albumin therapy in Spain.

Methods

A two-round national Delphi study was conducted among 47 hepatology experts from Spanish hospitals with broad geographic coverage. The survey included 40 Delphi statements and 14 items on opinion, attitude, and behaviour across five domains. Consensus was defined as Tastle's coefficient ≥ 0.8. Items with moderate consensus (0.7-0.79) and < 70% agreement, or < 0.7, were re-evaluated in round two.

Results

Long-term albumin was reportedly used in 25.5% of centers. However, panellists broa

SUBMITTER: Fortea JI 

PROVIDER: S-EPMC12613793 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature